1. Home
  2. NURO vs DOMH Comparison

NURO vs DOMH Comparison

Compare NURO & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • DOMH
  • Stock Information
  • Founded
  • NURO 1996
  • DOMH 1967
  • Country
  • NURO United States
  • DOMH United States
  • Employees
  • NURO N/A
  • DOMH N/A
  • Industry
  • NURO Medical/Dental Instruments
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NURO Health Care
  • DOMH Health Care
  • Exchange
  • NURO Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • NURO 8.2M
  • DOMH 8.8M
  • IPO Year
  • NURO N/A
  • DOMH N/A
  • Fundamental
  • Price
  • NURO $4.38
  • DOMH $6.87
  • Analyst Decision
  • NURO
  • DOMH
  • Analyst Count
  • NURO 0
  • DOMH 0
  • Target Price
  • NURO N/A
  • DOMH N/A
  • AVG Volume (30 Days)
  • NURO 22.9K
  • DOMH 3.3M
  • Earning Date
  • NURO 02-20-2025
  • DOMH 03-31-2025
  • Dividend Yield
  • NURO N/A
  • DOMH N/A
  • EPS Growth
  • NURO N/A
  • DOMH N/A
  • EPS
  • NURO N/A
  • DOMH N/A
  • Revenue
  • NURO $3,767,764.00
  • DOMH $12,589,000.00
  • Revenue This Year
  • NURO N/A
  • DOMH N/A
  • Revenue Next Year
  • NURO N/A
  • DOMH N/A
  • P/E Ratio
  • NURO N/A
  • DOMH N/A
  • Revenue Growth
  • NURO N/A
  • DOMH 1117.50
  • 52 Week Low
  • NURO $2.66
  • DOMH $0.83
  • 52 Week High
  • NURO $4.73
  • DOMH $11.33
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.52
  • DOMH 80.96
  • Support Level
  • NURO $4.16
  • DOMH $2.55
  • Resistance Level
  • NURO $4.39
  • DOMH $11.33
  • Average True Range (ATR)
  • NURO 0.08
  • DOMH 1.08
  • MACD
  • NURO 0.01
  • DOMH 0.50
  • Stochastic Oscillator
  • NURO 94.44
  • DOMH 54.63

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Share on Social Networks: